4th Quarter 2022 – The Parenthood Adventures!
In a previous life (ahead of remaining married with youngsters) I was very the traveler. Having said that, it has been several many years because I have been in a…
Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021
• Preliminary translational data validate UCARTCS1 as a promising potential therapy for relapsed orrefractory multiple myeloma patients. • Preclinical pipeline disclosed at Innovation Days : UCART20x22 for B-cell malignancies, UCARTMESO(targeting…
Gritstone Reports Second Quarter 2021 Financial Results and Business Update
GRANITE Phase 1/2 data of individualized neoantigen immunotherapy in advanced solid tumors accepted for mini- oral presentation at ESMO 2021 Gritstone-sponsored CORAL (second-generation SARS-CoV-2 vaccine) studies to launch before year-end…